Your browser doesn't support javascript.
loading
Multiscale networks in multiple sclerosis.
Kennedy, Keith E; Kerlero de Rosbo, Nicole; Uccelli, Antonio; Cellerino, Maria; Ivaldi, Federico; Contini, Paola; De Palma, Raffaele; Harbo, Hanne F; Berge, Tone; Bos, Steffan D; Høgestøl, Einar A; Brune-Ingebretsen, Synne; de Rodez Benavent, Sigrid A; Paul, Friedemann; Brandt, Alexander U; Bäcker-Koduah, Priscilla; Behrens, Janina; Kuchling, Joseph; Asseyer, Susanna; Scheel, Michael; Chien, Claudia; Zimmermann, Hanna; Motamedi, Seyedamirhosein; Kauer-Bonin, Josef; Saez-Rodriguez, Julio; Rinas, Melanie; Alexopoulos, Leonidas G; Andorra, Magi; Llufriu, Sara; Saiz, Albert; Blanco, Yolanda; Martinez-Heras, Eloy; Solana, Elisabeth; Pulido-Valdeolivas, Irene; Martinez-Lapiscina, Elena H; Garcia-Ojalvo, Jordi; Villoslada, Pablo.
Afiliação
  • Kennedy KE; Department of Medicine and Life Sciences, Universitat Pompeu Fabra, Barcelona, Spain.
  • Kerlero de Rosbo N; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • Uccelli A; TomaLab, Institute of Nanotechnology, Consiglio Nazionale delle Ricerche (CNR), Rome, Italy.
  • Cellerino M; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • Ivaldi F; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • Contini P; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • De Palma R; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • Harbo HF; Department of Neurology, Ospedale Policlinico San Martino-IRCCS and Department of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health, University of Genoa, Genoa Italy.
  • Berge T; Department of Neurology, University of Oslo, Oslo, Norway.
  • Bos SD; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Høgestøl EA; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Brune-Ingebretsen S; Oslo Metropolitan University, Oslo, Norway.
  • de Rodez Benavent SA; Department of Neurology, University of Oslo, Oslo, Norway.
  • Paul F; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Brandt AU; Department of Neurology, University of Oslo, Oslo, Norway.
  • Bäcker-Koduah P; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Behrens J; Department of Neurology, University of Oslo, Oslo, Norway.
  • Kuchling J; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Asseyer S; Department of Neurology, University of Oslo, Oslo, Norway.
  • Scheel M; Department of Neurology, Oslo University Hospital, Oslo, Norway.
  • Chien C; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Zimmermann H; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Motamedi S; Department of Neurology, University of California, Irvine, California, United States of America.
  • Kauer-Bonin J; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Saez-Rodriguez J; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Rinas M; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Alexopoulos LG; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Andorra M; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Llufriu S; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Saiz A; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Blanco Y; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Martinez-Heras E; Department of Neurology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, and Max Delbrueck Center for Molecular Medicine, Berlin, Germany.
  • Solana E; Institute for Computational Biomedicine, University of Heidelberg, Heidelberg, Germany.
  • Pulido-Valdeolivas I; Institute for Computational Biomedicine, University of Heidelberg, Heidelberg, Germany.
  • Martinez-Lapiscina EH; ProtATonce Ltd, Athens, Greece.
  • Garcia-Ojalvo J; School of Mechanical Engineering, National Technical University of Athens, Zografou, Greece.
  • Villoslada P; Center of Neuroimmunology, Hospital Clinic Barcelona, and Institut d'Investigacions Biomediques August Pi i Sunyer, Barcelona, Spain.
PLoS Comput Biol ; 20(2): e1010980, 2024 Feb.
Article em En | MEDLINE | ID: mdl-38329927
ABSTRACT
Complex diseases such as Multiple Sclerosis (MS) cover a wide range of biological scales, from genes and proteins to cells and tissues, up to the full organism. In fact, any phenotype for an organism is dictated by the interplay among these scales. We conducted a multilayer network analysis and deep phenotyping with multi-omics data (genomics, phosphoproteomics and cytomics), brain and retinal imaging, and clinical data, obtained from a multicenter prospective cohort of 328 patients and 90 healthy controls. Multilayer networks were constructed using mutual information for topological analysis, and Boolean simulations were constructed using Pearson correlation to identified paths within and among all layers. The path more commonly found from the Boolean simulations connects protein MK03, with total T cells, the thickness of the retinal nerve fiber layer (RNFL), and the walking speed. This path contains nodes involved in protein phosphorylation, glial cell differentiation, and regulation of stress-activated MAPK cascade, among others. Specific paths identified were subsequently analyzed by flow cytometry at the single-cell level. Combinations of several proteins (GSK3AB, HSBP1 or RS6) and immune cells (Th17, Th1 non-classic, CD8, CD8 Treg, CD56 neg, and B memory) were part of the paths explaining the clinical phenotype. The advantage of the path identified from the Boolean simulations is that it connects information about these known biological pathways with the layers at higher scales (retina damage and disability). Overall, the identified paths provide a means to connect the molecular aspects of MS with the overall phenotype.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Esclerose Múltipla Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article